AMANDA VENTIMIGLIA: Open Payments
NPI 1972845998 · FLORISSANT, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$937 in 37 payments from 13 companies in 2025. Trend: 2023 $1,409 · 2024 $1,585 · 2025 $937
Food & beverage: $937
| Company | Payments | Amount |
|---|---|---|
| Kestra Medical Technology Services, Inc. | 9 | $165 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $157 |
| Novartis Pharmaceuticals Corporation | 2 | $105 |
| Amgen Inc. | 6 | $104 |
| Edwards Lifesciences Corporation | 2 | $94 |
| Esperion Therapeutics, Inc. | 3 | $75 |
| Novo Nordisk Inc | 4 | $63 |
| SCPHARMACEUTICALS INC. | 2 | $44 |
| Alnylam Pharmaceuticals Inc. | 2 | $40 |
| E.R. Squibb & Sons, L.L.C. | 2 | $34 |
Products named: Assure WCD, Kerendia, LEQVIO, REPATHA, Edwards SAPIEN 3 Ultra Transcatheter Heart Valve, NEXLETOL, FUROSCIX, AMVUTTRA.
Industry payments across MO — which companies pay providers there.
